Resources Repository
-
ReportPublication 2017DCP3: Improving Health and Reducing Poverty
This report from the World Bank is the ninth and final volume of the Disease …
This report from the World Bank is the ninth and final volume of the Disease Control Priorities, Third Edition (DCP3) series. It provides an overview of the findings and methods explored in the first eight volumes, placing them within a framework that identifies an efficient pathway toward essential universal health coverage through the implementation of 21 essential packages that include health interventions and fiscal and intersectoral policies. The Disease Control Priorities Network (DCP) promotes and…
Evidence Synthesis | Government/Law | Costing Methods | Health Outcomes | Benefit-Cost Analysis | Cost-Effectiveness Analysis | Infectious Diseases | Maternal/Reproductive Health | Child/Nutrition | Chronic Disease/Risk | Mental Health | Injuries/Accidents | Social Determinants | Health Systems | Policy/Regulation | Global Governance | Economics/Finance | Health/Medicine | Science/Technology | Global -
OrganizationWeb Portal 2024Council of Economic Advisers
The Council of Economic Advisers is an agency within the Executive Office of the President …
The Council of Economic Advisers is an agency within the Executive Office of the President and is charged with offering the President objective economic advice on the formulation of both domestic and international economic policy. The Council bases its recommendations and analysis on economic research and empirical evidence, using the best data available to support the President in setting our nation's economic policy. Learn about recent news and reports.
Evidence Synthesis | Government/Law | Risk Analysis | Benefit-Cost Analysis | Cost-Effectiveness Analysis | Policy/Regulation | Economics/Finance | North America -
OrganizationWeb Portal 2024Institute for Clinical and Economic Review (ICER)
ICER is a non-profit organization that evaluates evidence on a range of topics including the value …
ICER is a non-profit organization that evaluates evidence on a range of topics including the value of medical tests, treatments and delivery system innovations and moves that evidence into action to improve the health care system. To accomplish this goal ICER performs analyses on effectiveness and costs, supports specific programs, and develops reports using innovative methods that make it easier to translate evidence into decisions that can align efforts to use evidence to drive improvements in both…
Evidence Synthesis | Government/Law | Preferences/Values | Priority Setting/Ethics | Value of Information | Cost-Effectiveness Analysis | Technology Assessment | Infectious Diseases | Chronic Disease/Risk | Mental Health | Health Systems | Business/Industry | Economics/Finance | Health/Medicine | Science/Technology | North America | Europe -
OrganizationWeb Portal 2024Operational Research Society
The Operational Research Society (ORS) was founded over 60 years ago as a successor to …
The Operational Research Society (ORS) was founded over 60 years ago as a successor to the Operations Research Club that had been set up in 1948. The UK’s OR Society is the oldest-established learned society catering to the Operational Research (O.R.) profession, and one of the largest in the world, with 2,700 members from 66 countries. Core activities of ORS include publishing journals to disseminate the latest developments in O.R., and organizing national, international and specialist conferences. The Journal…
Operations Research | Government/Law | Decision Analysis | Health/Medicine | Military/Defense | Global -
OrganizationWeb Portal 2024INFORMS
INFORMS is the leading international association for Operations Research & Analytics professionals. INFORMS publishes 16 …
INFORMS is the leading international association for Operations Research & Analytics professionals. INFORMS publishes 16 journals on topics ranging from decision analysis to management and marketing sciences and the INFORMS Resource Center offers information about O.R. and Analytics educational programs and material for students, faculty and others and offers a video library with on-demand access to key presentations from INFORMS meetings and conferences. They also offer a publication library bringing together recent publications across all of their…
Operations Research | Government/Law | Business/Industry | Climate/Environment | Energy/Engineering | Health/Medicine | Science/Technology | Global -
ReportPublication 2015Opioid Dependence: Final Report
This report from the Institute for Clinical and Economic Review (ICER) examines the comparative effectiveness and value …
This report from the Institute for Clinical and Economic Review (ICER) examines the comparative effectiveness and value of interventions for the management of opioid dependence. The goals of the report are to document the federal and New England state regulations affecting treatment options, provide an overview of existing clinical guidelines and payer coverage policies, and summarize the evidence on the different management approaches for opioid dependence, including special considerations for adolescents. An appendix is provided by ICER.…
Evidence Synthesis | Government/Law | Preferences/Values | Health Outcomes | Cost-Effectiveness Analysis | Technology Assessment | Chronic Disease/Risk | Mental Health | Health Systems | Policy/Regulation | Business/Industry | Health/Medicine | Science/Technology | North America -
ReportPublication 2014Redirecting Innovation in U.S. Health Care
This report from RAND Health explores methods of reducing health care spending and developing medical …
This report from RAND Health explores methods of reducing health care spending and developing medical products that provide cost value with health benefits. It summarizes literature and explores case studies to provide policy recommendations to meet these goals. It identifies a wide range of factors that affect the costs, risks, and rewards of medical product invention. Some of these features include treatment creep, the medical arms race, costs and risks of FDA approval, limited reward…
Evidence Synthesis | Government/Law | Costing Methods | Health Outcomes | Health Systems | Policy/Regulation | Economics/Finance | Health/Medicine | Science/Technology | North America